Related Experiment Videos
Large artery dilation produced by converting enzyme inhibition in hypertension: therapeutic aspects
Insights
Angiotensin-converting enzyme (ACE) inhibitors dilate large arteries in hypertensive patients, improving arterial compliance. Higher doses are needed for large artery effects compared to blood pressure reduction, impacting long-term cardiovascular treatment strategies.
Area of Science:
- Cardiovascular Pharmacology
- Hypertension Research
- Arterial Physiology
Background:
- Hypertension is associated with arterial stiffening and remodeling.
- Angiotensin-converting enzyme (ACE) inhibitors are widely used to manage hypertension.
- The effects of ACE inhibitors on large artery properties require further elucidation.
Purpose of the Study:
- To investigate the impact of ACE inhibition on large artery dilation and compliance in hypertensive subjects.
- To compare the effective dosages for large artery dilation versus blood pressure reduction.
- To assess the implications for long-term antihypertensive therapy and cardiovascular remodeling.
Main Methods:
- Administration of ACE inhibitors to hypertensive subjects and healthy volunteers.
- Measurement of blood pressure and arterial dimensions.
- Assessment of arterial compliance and smooth muscle relaxation.
Main Results:
- ACE inhibition induced significant large artery dilation in hypertensive subjects, independent of blood pressure reduction.
- Increased arterial compliance was observed, attributed to both blood pressure decrease and smooth muscle relaxation.
- Dosages required for large artery dilation were higher than those for arteriolar dilation and blood pressure reduction.
Conclusions:
- ACE inhibitors exert beneficial effects on large artery properties beyond blood pressure lowering.
- These findings suggest a role for ACE inhibitors in mitigating arterial remodeling in hypertensive patients.
- The results have implications for optimizing antihypertensive treatment strategies, especially in long-term cardiovascular care.
Abstract:
Large artery dilation is produced by angiotensin-converting enzyme inhibition in hypertensive subjects despite a significant blood pressure reduction. The resulting increase in arterial compliance may be due both to blood pressure decrease and to arterial smooth muscle relaxation. In healthy volunteers and in hypertensive subjects, dosages causing large artery dilation seem to be higher than those causing pure arteriolar dilation with resulting blood pressure reduction. Similar findings have been noted to obtain compliance enhancement. Such results may be important in considering antihypertensive therapy, particularly when remodeling of the cardiovascular system is considered in long-term treatment.